Merck Unveils Virus Vaccine Candidates While Warning on Timeline

  • R&D program includes developing antiviral discovered at Emory
  • ‘Talking about vaccinating the world:’ chief patient officer
Lock
This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Merck & Co. moved to bolster the global fight against the coronavirus, unveiling plans for a pill to treat the infection and two vaccines to prevent it, though a top executive cautioned it may take longer than expected to deliver a vaccine and make it available globally.